BML Capital Management, LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
-22,962
(-17.4%)
New positions
6
Sold out positions
10
Turnover %
24.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ADVM | 7,277 | 110.7% |
| ACRS | 6,840 | 33.8% |
| PMVP | 2,109 | 39.8% |
| CNTB | 1,914 | NEW |
| IMA | 1,487 | NEW |
| ORMP | 1,424 | 20.5% |
| LONA | 1,337 | NEW |
| ALMS | 1,199 | 33.0% |
| TGT | 897 | NEW |
| LAVA Therapeutics NV | 473 | 18.2% |
Top Reduces (Value $000, Stocks/ETFs)
| Third Harmonic Bio, Inc. | -20,767 | -100.0% |
| EPIX | -7,177 | -100.0% |
| AVIR | -5,721 | -20.9% |
| IMA | -5,400 | -100.0% |
| MIST | -2,204 | -100.0% |
| Elevation Oncology, Inc. | -2,162 | -100.0% |
| CNTB | -1,785 | -100.0% |
| LONA | -976 | -100.0% |
| CRVS | -475 | -100.0% |
| Turnstone Biologics Corp. | -396 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
519
(0.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|